Patents by Inventor Isabelle OPALINSKI

Isabelle OPALINSKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Conjugates and prodrugs for treating cancer and inflammatory diseases
    Patent number: 10293021
    Abstract: The present invention relates to the field of cancer and inflammatory diseases. More particularly, it aims to provide, for these purposes, novel conjugated forms of active ingredients belonging to the dolastatin family and having the formula as follows: It is also directed towards prodrug forms of these conjugates.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: May 21, 2019
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE POITIERS
    Inventors: Sebastien Papot, Isabelle Opalinski, Brigitte Renoux, Thibaut Legigan
  • CONJUGATES AND PRODRUGS FOR TREATING OF CANCER AND INFLAMMATORY DISEASES
    Publication number: 20170095525
    Abstract: The present invention relates to the field of cancer and inflammatory diseases. More particularly, it aims to provide, for these purposes, novel conjugated forms of active ingredients belonging to the dolastatin family and having the formula as follows: It is also directed towards prodrug forms of these conjugates.
    Type: Application
    Filed: February 6, 2015
    Publication date: April 6, 2017
    Inventors: Sebastien Papot, Isabelle OPALINSKI, Brigitte RENOUX, Thibaut LEGIGAN